Cellcura signs HSA-free media deal with IDT for vacc development
CellCura has inked an agreement with IDT Biologika for the testing and adaptation of its protein-free (PF) media for the production of cell lines for vaccine manufacturing.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs